Montelukast Prescribing at NEXUS HEALTH GROUP
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,788
Total Quantity
58.5K
NHS Cost
£3.0K
vs National Avg
+161.1%
NEXUS HEALTH GROUP prescribed 1,788 items of Montelukast over the last 12 months at a cost of £3,039 to the NHS. This is 161.1% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
144
Jul 2026
154
Jul 2026
168
Jul 2026
125
Jul 2026
140
Jul 2026
167
Jul 2026
142
Jul 2026
179
Jul 2026
165
Jul 2026
134
Jul 2026
138
Jul 2026
132
Prescribing Details
| Total Items | 1,788 |
|---|---|
| Total Quantity | 58,548 |
| Total NHS Cost | £3,039 |
| Presentations | 4 different forms |
| vs National Average | +161.1% |
Montelukast Prescribing Comparison
| This practice | 1,788 items |
|---|---|
| National average per practice | 685 items |
| Difference | +161.1% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.